March 3, 2014 by Brad Perriello
EarLens said it raised some $36 million in an equity round for the hearing aid technology it’s developing that uses infrared rather than sound waves.
Cheetah Medical said it added another $9 million to its coffers in a funding round led by Fletcher Spaght Ventures.
The Newton, Mass.-based medical device company, which makes a non-invasive hemodynamic monitoring system, said Springfield Investment Management, MVM Life Science Partners, Robert Bosch Venture Capital and Ascension Health Ventures also participated in the round.
Cheetah Medical shook up the C-suite this week, added a new CEO and a new medical chief – plus $14.5 million to the fluid management device maker’s coffers.